Production and Cultivation

At Medicinal Organic Cannabis Australia (MOCA) Pty Ltd, we are committed to the ethical, sustainable, and compliant cultivation and production of high-quality medicinal cannabis. Our operations adhere to the strict regulatory frameworks established by the Therapeutic Goods Administration (TGA) and the Office of Drug Control (ODC), ensuring that all products meet Australian pharmaceutical standards.

Our Approach to Medicinal Cannabis Cultivation

MOCA follows best practices in organic cultivation and pharmaceutical-grade processing to ensure safety, consistency, and efficacy in all medicinal cannabis products. Our cultivation practices are designed to support patients and healthcare providers by delivering high-quality cannabis that meets strict regulatory and scientific standards.

Regulatory Compliance & Licensing

MOCA operates under licenses issued by the ODC, in compliance with the Narcotic Drugs Act 1967. These regulations govern the cultivation, production, and manufacturing of medicinal cannabis to ensure patient safety and product integrity. All cultivation and processing activities comply with Good Manufacturing Practice (GMP) standards, as required by Australian law.

Our facility is subject to regular inspections and stringent quality control measures to ensure compliance with all applicable laws. This guarantees that our medicinal cannabis products are safe, effective, and available only via prescription.

Sustainable & Controlled Cultivation Methods

MOCA prioritizes sustainability and environmental responsibility in its cultivation process. Our growing methods incorporate:

• Organic growing techniques to maintain product purity and reduce environmental impact.

• Controlled indoor and greenhouse environments for optimal plant health and cannabinoid consistency.

• Advanced monitoring systems to track plant growth, humidity, and light exposure, ensuring uniformity and quality in every batch.

• Water conservation and energy-efficient practices to minimise our ecological footprint while maintaining pharmaceutical-grade production.

Stringent Quality Control & Testing

Every batch of medicinal cannabis produced by MOCA undergoes rigorous laboratory testing and quality assurance protocols. Our third-party testing includes:

• Cannabinoid profile analysis to ensure accurate potency levels.

• Microbial and contaminant screening to eliminate harmful bacteria, pesticides, or heavy metals.

• Terpene profiling to maintain consistency in product aroma and therapeutic characteristics.

• Stability testing to ensure product efficacy over time.

All test results comply with TGA standards, ensuring that healthcare providers and patients receive reliable, high-quality medicinal cannabis products.

Production & Formulation

MOCA’s state-of-the-art production facilities utilise pharmaceutical-grade extraction and processing techniques to develop a range of medicinal cannabis products. These include:

• Oils and tinctures for controlled dosing and patient-specific formulations.

• Cannabis flower for vaporisation under medical supervision.

• Other medicinal cannabis formulations in compliance with Australian regulations.

Commitment to Research & Development

MOCA is actively involved in ongoing research and innovation to improve medicinal cannabis production. We collaborate with universities, healthcare professionals, and regulatory bodies to advance the scientific understanding of medicinal cannabis and ensure our cultivation techniques align with the latest medical research.

TGA Disclaimer

All medicinal cannabis products cultivated and produced by MOCA are available only via prescription and in compliance with Australian regulations. MOCA does not sell cannabis products directly to consumers. Any information provided on this website is for educational purposes only and should not be interpreted as medical advice.